期刊文献+

小鼠可溶性B淋巴细胞刺激因子真核表达载体pSecTag2B-msBlyS的构建

Construction of Eukaryotic Expression Plasmid pSecTag2B-msBlyS Expressing Mouse Soluble B Lymphocyte Stimulator
下载PDF
导出
摘要 目的 克隆BALB c小鼠可溶性B淋巴细胞刺激因子 (msBlyS)的cDNA片段并测序分析 ,为研究msBlyS诱导的抗肿瘤作用提供目的基因。方法 采用反转录聚合酶联反应 (RT_PCR)法从BALB c小鼠脾脏组织总RNA中获得 5 6 6bp的msBlyS基因cDNA。通过TA克隆测序无误 ,再将其定向连接到pSecTag2B真核表达载体上 ,转化E .coliXL1_blue。限制性内切酶筛选出阳性克隆pSecTag2B_msBlyS ,末端终止法完成msBlyScDNA的序列测定。结果 测得的msBlyScDNA序列与基因文库中报道序列完全相同 ,插入相位正确 ,未改变目的基因的阅读框架。结论 成功克隆了小鼠可溶性B淋巴细胞刺激因子基因 ,为研究其诱导的抗肿瘤作用奠定了基础。 Objective The purpose of this study was to clone the soluble form of the mouse BlyS (msBlyS) and insert it into a eukaryotic expression vector pSecTag2B in order to further elucidat the antitumor activity induced by msBlyS expressed by the recombined plasmid pSecTag2B-msBlyS.Methods Full length cDNA of mouse soluble BlyS (msBlyS ) was amplified by reverse transcription-PCR from total RNA of mouse spleen. The PCR product was ligated directly with linearized vector pCR2.1 supplied in the TA cloning kit. The recombined plasmid pCR2.1-msBlyS which was selected and identified using blue-white screening method and restriction map analysis and the purified original plasmid pSecTag2B were both cut by HindⅢ and EcoRⅠ. The digested fragments were extracted and purified from low-melting temperature agarose and ligated by T4DNA ligase. The recombined plasmid pSecTag2B-msBlyS were isolated and identified by restricted endonuclease cutting and Sanger dideoxy DNA sequencing. Results The sequencing data indicated that inserted msBlyS gene had correct DNA sequence and orientation.Conclusion Eukaryotic expression vector pSecTag2B. Expressing mouse BlyS have sucessfully been cloned. This will provide us an opportunity to do further research work on BlyS.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2004年第2期145-148,共4页 West China Journal of Stomatology
基金 国家重点基础研究发展规划 (973)项目 (2 0 0 1CB51 0 0 0 1 ) 973前期资助项目 (2 0 0 1_50 )
  • 相关文献

参考文献11

  • 1陈光宇,邹民吉,彭善云,王嘉玺.重组人可溶性B淋巴细胞刺激因子及其突变体的克隆、表达及活性测定[J].生物化学与生物物理学报,2002,34(6):731-736. 被引量:4
  • 2Moore PA,Belvedere O,Orr A,et al.BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator[J].Science,1999,285(5425):260-263.
  • 3Mukhopadhyay A,Ni J,Zhai Y,et al.Identification and characterization of a novel cytokine,THANK,a TNF Homologue that activates apotosis,nuclear factorκβand c-Jun NH2-terminal kinase[J].J Biol Chem,1999,274(23):15978-15981.
  • 4Schneider P,Mackay F,Steineer V,et al.BAFF,a novel ligand of the tumor necrosis factor family,stimulates B cell growth[J].J Exp Med,1999,189(11):1747-1756.
  • 5Shu HB,Hu WH,Johnson H.Tall-1 is a novel member of the TNF family that is down regulated by mitogens[J].J Leukoc Biol,1999,65(5):680-683.
  • 6Schiemann B,Gommerman JL,Vora K,et al.An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway[J].Science ,2001,293(5537):2111-2114.
  • 7Khare SD,Sarosi I,Xia XZ,et al.Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice[J].Proc Natl Acad Sci USA,2000,97(7):3370-3375.
  • 8Cheema GS,Roschke V,Hilbert DM,et al.Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases[J].Arthritis Rheum,2001 ,44(6):1313-1319.
  • 9Zhang J,Roschke V,Baker KP,et al.Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus[J].J Immunol,2001,166(1):6-10.
  • 10Yoshimura K,Hazama S,Iizuka N,et al.Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igκleader sequence[J].Cancer Gene Therapy,2001,8(1):9-16.

二级参考文献10

  • 1Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P,Soppet D et al. BlyS: Member of the tumor necrosis factor familyand B lymphocyte stimulator. Science, 1999, 285(5425): 260-263
  • 2Khare SD, Sarosi I, Xia XZ, McCabe SS, Miner K, Solovyev I,Hawkins Net al. Severe B cell hyperplasia and autoimrntme disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA, 2000, 97(7):3370-3375
  • 3Schneider P, Mackay F, Steiner V, Hofmann K, Bodrner JL,Holler N, Ambrose C et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Meal,1999, 189(11): 1747-1756
  • 4Shu FIB, Hu WH, Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol,1999, 65(5): 680-683
  • 5Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS,Migone TS, Sosnovtseva Set al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood, 2001, 97 ( 1 ) :198-204
  • 6Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989
  • 7Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 72:248-254
  • 8Scttiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science, 2001, 293(5537): 2111-2114
  • 9Liu P, Zhang SQ, Yan XM, Huang HJ, Zhou KY. Cloning, expression, purification and activity of the hsBLyS. Acta Biochim Biophys Sin, 2001, 33(2): 210-214(引自:生物化学与生物物理学报)
  • 10Bodmer JL, Meier P, Tschopp J, Schneider P. Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL.J Biol Chem, 2000, 275(27) : 20632-20637

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部